Carol Schafer

CIK: 0001272181

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

IMNM

Immunome Inc.

Director

KURA

Kura Oncology, Inc.

Director

INSM

INSMED Inc

Director

RPTX

Repare Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

IMNM
Immunome Inc.
Jun 10, 2026
Award(A)
Director Stock Option (right to buy)
Direct
9.9K shares-
KURA
Kura Oncology, Inc.
Jun 4, 2026
Award(A)
Option to purchase common stock
Direct
35K shares-
INSM
INSMED Inc
May 13, 2026
Award(A)
Direct
3.3K shares-
RPTX
Repare Therapeutics Inc.
Jan 28, 2026
Disposition(D)
Direct
8K shares-
IMNM
Immunome Inc.
Jun 10, 2025
Award(A)
Director Stock Option (right to buy)
Direct
18.9K shares-
KURA
Kura Oncology, Inc.
Jun 5, 2025
Award(A)
Option to purchase common stock
Direct
28.5K shares-
INSM
INSMED Inc
May 15, 2025
Award(A)
Direct
5.1K shares-

		Type	Shares	Price		Ownership
Jun 10, 2026	IMNM Immunome Inc.	Award(A) Director Stock Option (right to buy)	9,897	-	-	Direct
Jun 4, 2026	KURA Kura Oncology, Inc.	Award(A) Option to purchase common stock	35,000	-	-	Direct
May 13, 2026	INSM INSMED Inc	Award(A)	3,305	-	$0	Direct
Jan 28, 2026	RPTX Repare Therapeutics Inc.	Disposition(D)	8,000	-	$0	Direct
Jun 10, 2025	IMNM Immunome Inc.	Award(A) Director Stock Option (right to buy)	18,864	-	-	Direct
Jun 5, 2025	KURA Kura Oncology, Inc.	Award(A) Option to purchase common stock	28,500	-	-	Direct
May 15, 2025	INSM INSMED Inc	Award(A)	5,058	-	-	Direct

1-7 of 7 transactions

About SCHAFER CAROL

SCHAFER CAROL (SEC CIK 0001272181) files insider reports with the SEC as Director of Immunome Inc. (IMNM), Director of Kura Oncology, Inc. (KURA) and Director of INSMED Inc (INSM). Signal8 also holds filings tied to 1 other company.

Signal8 holds 7 ownership filings by SCHAFER CAROL, all Form 4s, filed between May 19, 2025 and Jun 12, 2026. Those filings report 7 transactions, from May 15, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SCHAFER CAROL's filings is in SAN DIEGO, CA.

Recent filings by SCHAFER CAROL

Jun 10, 2026: Grant or award of IMNM derivative securities (Form 4, code A).
Jun 4, 2026: Grant or award of KURA derivative securities (Form 4, code A).
May 13, 2026: Grant or award of INSM shares (Form 4, code A).
Jan 28, 2026: Disposition to issuer transaction of RPTX shares (Form 4, code D).
Jun 10, 2025: Grant or award of IMNM derivative securities (Form 4, code A).

Other insiders filing for Immunome Inc. (IMNM)

Higgins Jack, Chief Scientific Officer
Barchas Isaac, Director
Horn Kinney, CHIEF BUSINESS OFFICER
Tsai Philip, Chief Technical Officer
Stoneman Sandra G., CHIEF LEGAL OFFICER & GC
Rosett Max, Chief Financial Officer

How to read Form 4 transaction codes